SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?


To: Tenchusatsu who wrote (1578375)12/19/2025 12:04:33 PM
From: combjelly  Read Replies (1) | Respond to of 1579256
 
He overestimates how much AI can do these days, and he overestimates how much he and his minions can figure out all on their own.


I am not sure how much he overestimates, but he sure over-hypes both. I still strongly suspect he sold DOGE to Trump by pushing the idea that once he got access to all of the government data, he'd be able to totally automate government offices and get rid of the bureaucrats.

I mean, how hard can it be?



To: Tenchusatsu who wrote (1578375)12/19/2025 12:19:41 PM
From: Broken_Clock2 Recommendations

Recommended By
bjzimmy
longz

  Read Replies (1) | Respond to of 1579256
 
Former FDA vaccine advisor and top vaccine pimp Paul Offit, speaking with Big Pharma twink mascot “Doctor Mike,” recently discussed why myocarditis in boys receiving the COVID shots and blood clots in the brain from the failed J&J shot were “very small prices to pay.”

“You’re always, always waiting for the other shoe to drop. And it did drop.


I mean, with the mRNA vaccines, there was myocarditis, which was inflammation of heart muscle, primarily in boys 16-29 years of age, primarily after second dose, primarily within 4 days, but generally it was transient and self-resolving, so it really wasn’t that bad.

That was a very small price to pay, I think, for that vaccine.

But you had J&J’s vaccine, which we reviewed in February of 2021, the adenovirus vector vaccine. And that was, again, about a 30,000-person study. So you saw 15,000 people got that vaccine, then millions of people got it. And it was found to be a cause of clotting, including severe clotting, including clotting in brain, that ultimately drove that vaccine off the market by March of 2023.

And everybody looks at that story and they say, ‘How did you not know that? How did you recommend something like that which now has caused deaths in some people? How could you not know that’? And people then lose trust, which is in part sort of why I wrote this book, because I just think people just have to have realistic expectations of the fact that you’re going to learn as you go.”